Table 1.
HRCS Research Activity Group | 2004/2005 | 2009/2010 | 2014 (HRAF) | Difference in 2014 (£) | Difference in 2014 (%) | |||||
---|---|---|---|---|---|---|---|---|---|---|
Value (£m) | % | Value (£m) | % | Value (£m) | % | vs. 04/05 | vs. 09/10 | vs. 04/05 | vs. 09/10 | |
1 Underpinning | 401.7 | 33.6% | 488.7 | 27.6% | 453.5 | 23.9% | 51.8 | –35.2 | –9.7% | –3.7% |
2 Aetiology | 414.4 | 34.7% | 563.1 | 31.8% | 558.4 | 29.4% | 144. | –4.7 | –5.2% | –2.3% |
3 Prevention | 29.6 | 2.5% | 66.4 | 3.7% | 101.5 | 5.4% | 71.9 | 35.2 | 2.9% | 1.6% |
4 Detection and Diagnosis | 62.9 | 5.3% | 129.9 | 7.3% | 189.0 | 10.0% | 126.1 | 59.1 | 4.7% | 2.6% |
5 Treatment Development | 102.9 | 8.6% | 189.3 | 10.7% | 228.8 | 12.1% | 126.0 | 39.6 | 3.5% | 1.4% |
6 Treatment Evaluation | 99.0 | 8.3% | 151.5 | 8.5% | 179.0 | 9.4% | 79.9 | 27.5 | 1.1% | 0.9% |
7 Disease Management | 27.7 | 2.3% | 57.3 | 3.2% | 71.4 | 3.8% | 43.7 | 14.1 | 1.4% | 0.5% |
8 Health Services | 56.2 | 4.7% | 126.1 | 7.1% | 114.9 | 6.1% | 58.7 | –11.2 | 1.4% | –1.1% |
Grand Total | 1194.3 | 100% | 1772.3 | 100% | 1896.5 | 100% | 702.1 | 124.2 | 0.0% | 0.0% |
Note (Table 1 and Figure 1): The 2004/2005 analysis did not include Arthritis Research UK, so data from this charity was added retrospectively in comparisons in the 2009/2010 analysis. The 2014 analysis included contributions from 64 research organisations, however, to allow comparable data with previous analyses, only the Health Research Analysis Forum (HRAF) group funders (original 11 plus Arthritis Research UK) are included here. Award values are in 2014 real terms, extrapolated from original spend using GDP deflator data as of December 2014. See the United Kingdom Health Research Analysis 2014 main report for more details